New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 10, 2013
17:03 EDTVRXValeant announces information regarding continuance proposal
Valeant Pharmaceuticals announced that it has provided additional information related to the proposal to continue Valeant into British Columbia under the British Columbia Business Corporations Act, or BCBCA. If the continuance is approved by shareholders, Valeant's current articles and by-laws will be replaced with a notice of articles and articles under the BCBCA. The new articles provide that shareholders seeking to nominate candidates for election as directors must provide timely written notice to Valeant. Valeant has modified the advance notice provision to provide that a shareholder's notice must be received by Valeant no later than the close of business on the 50th day before the meeting date.
News For VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
07:29 EDTVRXValeant selected as lead bidder to acquire Dendreon, Provenge for $296M
Subscribe for More Information
05:20 EDTVRXDendreon reaches agreement for Valeant to serve as 'stalking horse bidder'
Subscribe for More Information
January 22, 2015
05:57 EDTVRXActavis, Valeant raise prospects of more healthcare deals, Financial Times says
Subscribe for More Information
January 21, 2015
12:30 EDTVRXGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use